Avastin for Diabetic Macular Edema: Costs, Benefits, Risks, and What to Expect

Published by Dr. Manolette Roque at March 11, 2026

Avastin for Diabetic Macular Edema

🤖 Quick Answer: Avastin for diabetic macular edema is an anti-VEGF medicine called bevacizumab that eye doctors may inject into the eye to reduce retinal leakage and swelling. It is often chosen because it is less expensive than some alternatives, but it is commonly used off-label and may need repeated treatment and OCT monitoring.

Diabetic macular edema, often shortened to DME, happens when diabetes damages retinal blood vessels and allows fluid to leak into the macula. The macula is the part of the retina that gives you sharp reading vision, face recognition, and fine detail. When it swells, vision may become blurred, distorted, or washed out.

One treatment option for DME is Avastin, the brand name for bevacizumab. Retina specialists may use Avastin injections to reduce swelling and help stabilize or improve vision. This guide explains what Avastin is, how it works, what patients can realistically expect, and why some doctors choose it over other anti-VEGF medicines.

🧩 Focus: Avastin (bevacizumab) treatment for diabetic macular edema
👁 Goal: Explain who may benefit, how treatment works, and what follow-up is needed
🛡 Evidence-Based: Preferred Practice Patterns • Standards of Care • Systematic Reviews • Meta-Analyses

🧠 Diabetic Eye Disease Knowledge Hub

Start with the complete guide:
Diabetic Eye Disease: The Complete Patient Guide

📌 Key Learning Points

Avastin is bevacizumab, an anti-VEGF medicine used to reduce retinal leakage and swelling in diabetic macular edema.
In eye care, Avastin is commonly used off-label, which means it is not the original FDA-approved eye label, but doctors may still use it when evidence and clinical judgment support it.
Avastin is often chosen because it is less expensive than some other anti-VEGF drugs.
Many patients need repeated injections and regular OCT scans, not just one treatment.
Some eyes respond very well to Avastin, while others may do better after switching to another medicine if swelling persists.

👁 What Is Avastin for Diabetic Macular Edema?

Avastin is the brand name for bevacizumab, a medicine that blocks vascular endothelial growth factor, usually shortened to VEGF. VEGF is a signal that encourages blood vessels to leak and grow abnormally. In diabetic macular edema, high VEGF activity contributes to leakage from damaged retinal vessels, which leads to swelling in the macula.

By blocking VEGF, Avastin can reduce leakage, shrink macular swelling, and help protect central vision. Retina specialists inject the medicine directly into the eye using a very small needle in a carefully prepared clinic setting.

It is important to understand one key point: Avastin is widely used in retina practice, but its original product label is for intravenous use in certain cancers, not for eye injection. In eye care, its use is commonly described as off-label. Off-label use does not automatically mean inappropriate. It means the medicine is being used in a way not specifically listed on the original approval label, based on published evidence and specialist judgment.

💡 Analogy: Think of the macula like the sharp center of a camera screen. Diabetic macular edema is like water leaking behind that screen and making the picture blurry. Avastin works like turning down the leak so the screen can dry out and become clearer.

Why Doctors Use Avastin for DME

Retina doctors may choose Avastin for several reasons. The biggest practical reason is often cost. Compared with some other anti-VEGF medicines, Avastin is frequently much less expensive, which can make ongoing treatment more realistic for many patients.

That matters because DME is rarely a one-injection problem. It usually behaves like a chronic retinal disease that needs repeated treatment and close follow-up. A medicine that is financially sustainable may help patients stick with care longer.

Another reason is that Avastin has been studied in major diabetic macular edema trials. In the DRCR Protocol T study, eyes treated with aflibercept, bevacizumab, or ranibizumab all improved on average, but the amount of benefit varied depending on how poor the starting vision was. When starting vision loss was milder, the average differences among drugs were smaller. When starting vision was worse, aflibercept performed better on average. That does not mean Avastin never works well. It means patient selection matters.

More recently, Protocol AC tested a practical strategy that many doctors already use in real life: start with bevacizumab, then switch to aflibercept if the response is not strong enough. This kind of stepwise approach may balance affordability with the option to intensify treatment when needed.

🧪 What the Injection Procedure Is Like

Many patients feel nervous before their first eye injection. That is completely understandable. The good news is that the procedure is usually short, controlled, and done under local anesthetic drops.

What usually happens on injection day

Your vision and eye pressure may be checked.
The eye and surrounding skin are cleaned carefully.
Numbing drops are used so the surface feels more comfortable.
A small eyelid holder may be used to keep you from blinking.
The injection is given through the white part of the eye using a very fine needle.

Most patients describe the treatment as pressure or brief discomfort rather than severe pain. Afterward, the eye may feel scratchy or mildly irritated for a day or two.

Read the full step-by-step guide here: Anti-VEGF Injection Procedure.

💊 What Results Can Patients Expect?

Avastin can help in two main ways:

It can reduce macular swelling seen on OCT scans.
It can stabilize or improve vision in many eyes with center-involving diabetic macular edema.

However, results are not identical for everyone. Some eyes respond dramatically. Others improve more slowly. A few show only limited benefit and may need a switch to another medicine or an added treatment strategy.

The starting condition of the retina matters. If swelling has been present for a long time, or if the retina already has significant structural damage, full visual recovery may not be possible even if the OCT improves. That is one reason why early treatment usually gives the best chance of preserving useful vision.

Patients should think in terms of control, not just cure. The goal is often to make the retina drier, preserve vision, improve reading ability when possible, and reduce the risk of further deterioration.

How Often Are Avastin Injections Needed?

There is no single schedule that fits every patient. Many treatment plans start with a more intensive early phase, followed by follow-up visits and repeat injections based on OCT findings, vision, and retinal response.

In practical terms, many retina specialists begin with monthly treatment or monthly monitoring during the active phase. If the retina improves, intervals may sometimes be adjusted. If swelling persists, treatment may continue monthly, or the doctor may recommend switching medicines.

A major mistake is assuming that one injection means the problem is solved. DME often needs repeated treatment over time. Skipping follow-up can allow swelling to return and may reduce the chance of the best visual outcome.

Read more here: Anti-VEGF Treatment Schedule.

Risks and Side Effects

Most injections are completed without major problems, but no eye procedure is completely risk-free.

Common short-term effects

Mild redness
Scratchy or irritated feeling
Tearing
Temporary blurry vision
Small blood spot on the white of the eye

Less common but important risks

Eye infection inside the eye (endophthalmitis)
Inflammation
Retinal tear or detachment
Increased eye pressure
Bleeding

🚨 Emergency Warning
Seek urgent ophthalmic evaluation after an injection if you develop severe eye pain, rapidly worsening redness, major light sensitivity, marked vision drop, or thick discharge. These symptoms may signal a serious complication and should not be ignored.

Patients should also understand the compounding issue. Since Avastin is not supplied in a standard single-use ophthalmic dose from its original oncology packaging, eye doses are typically prepared for ophthalmic use through sterile repackaging processes. Your doctor or eye center should follow careful safety protocols.

Avastin vs Other Anti-VEGF Options

The main anti-VEGF choices discussed in DME care often include:

Why Avastin is attractive

Lower cost
Long clinical experience in retina practice
May work well for many eyes, especially in practical real-world care

Why another drug may be chosen instead

Starting vision is significantly worse
The retina remains swollen despite repeated Avastin treatment
The doctor wants a different durability or response profile

In other words, Avastin is not “good” or “bad” in a simple way. It is one important option in a treatment toolbox. The best choice depends on the OCT pattern, starting vision, treatment burden, affordability, and the individual eye’s response.

Why OCT Follow-Up Matters

OCT, or optical coherence tomography, is one of the most useful tests in diabetic macular edema. It shows whether the retina is thickened, how much fluid remains, and whether treatment is working.

Think of OCT as the eye doctor’s “retina ruler.” It measures swelling more precisely than vision alone. A patient may say, “I think I’m seeing a little better,” but the OCT helps determine whether the macula is truly getting drier or whether fluid is still threatening central vision.

Read more here: OCT for Diabetic Macular Edema.

Continue Reading

🏁 Take-Home Message

Avastin is a commonly used anti-VEGF option for diabetic macular edema, especially when affordability matters. It can reduce retinal swelling and protect vision, but most patients need repeated injections and OCT follow-up rather than a one-time treatment.

If your retina does not improve enough with Avastin, your doctor may recommend switching to another medicine instead of simply waiting longer.

❓ Frequently Asked Questions

Is Avastin approved specifically for diabetic macular edema?
Avastin’s original approval is for intravenous oncology use. In eye care, retina specialists commonly use it off-label for diseases such as diabetic macular edema.

Why do some doctors choose Avastin first?
Avastin is often much less expensive than some alternatives, so it may be a practical first anti-VEGF option for long-term treatment.

Does Avastin work as well as every other anti-VEGF medicine?
Not always in every situation. Some eyes do very well with Avastin, while others—especially with worse starting vision—may respond better on average to another medicine.

How many Avastin injections will I need?
Many patients need repeated injections and regular monitoring. Treatment is usually ongoing and guided by OCT scans and vision response.

What should I do if my eye hurts badly after an injection?
Severe pain, worsening redness, or a major vision drop after an injection needs urgent eye evaluation because it may signal a serious complication.

📚 References

American Academy of Ophthalmology. Diabetic Retinopathy Preferred Practice Pattern. 2024 update.
National Eye Institute. Macular Edema.
Wells JA, et al. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. New England Journal of Medicine. 2015.
Jhaveri CD, et al. Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema. New England Journal of Medicine. 2022.
Genentech. Avastin Prescribing Information.

🤝 Roque Eye Clinic Patient Education Series

Reviewed by the Roque Advisory Council
Dr Manolette Roque | Dr Barbara Roque
St Luke’s Medical Center Global City | Asian Hospital Medical Center
Philippines

Medical Review: Roque Advisory Council
Last Updated: March 2026

This article is intended for educational purposes only and does not replace professional medical consultation.

ANIMATION

Intravitreal Injections
IVI Risks

BOOK AN APPOINTMENT

It takes less than 5 minutes to complete your online booking. Alternatively, you may call our BGC Clinic, or our Alabang Clinic for assistance.

Dr. Manolette Roque

Dr. Manolette Roque is an ophthalmologist whose practice includes general ophthalmology (which includes cataract surgery) with subspecialty work in uveitis and ocular immunology, cornea and external disease, and refractive surgery.